Science Explorer Interactive view Map
Company · Pointe-Claire · Canada

Telesta Therapeutics (Canada)

telestatherapeutics.comROR OpenAlex
Research works
6
▲ 45% vs 2013–17
Citations
139
21.6 per fractional work
Top-10% rate
24.7%
record average 16.5%
Open access
69%
world 28%

Not ranked overall: Telesta Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Telesta Therapeutics (Canada) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, DNA Repair Mechanisms, interferon and immune responses and Ubiquitin and proteasome pathways.

PARP inhibition in cancer therapy: 1 fractional worksDNA Repair Mechanisms: 0 fractional worksinterferon and immune re…0interferon and immune responses: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksInfluenza Virus Research Studies: 0 fractional worksHormonal Regulation and Hypertension: 0 fractional worksNuclear Receptors and Si…0Nuclear Receptors and Signaling: 0 fractional worksEffects of Radiation Exposure: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional works
OncologyMolecular BiologyImmunologyEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 1 works
  2. 2 DNA Repair Mechanisms Molecular Biology 0 works
  3. 3 interferon and immune responses Immunology 0 works
  4. 4 Ubiquitin and proteasome pathways Molecular Biology 0 works
  5. 5 Influenza Virus Research Studies Epidemiology 0 works
  6. 6 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  8. 8 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Autophagy in Disease and Therapy Epidemiology 0 works
  10. 10 CRISPR and Genetic Engineering Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available69.2%not open30.8%

World: 28% of research is openly available.

with international co-authors66.2%domestic only33.8%

World: 19% is written across borders.

How has Telesta Therapeutics (Canada)'s research output changed?

Output in 2018–2022 was 45% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Pointe-Claire

All research institutions in Pointe-Claire

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.